Suven Pharmaceuticals Ltd
NSE:SUVENPHAR

Watchlist Manager
Suven Pharmaceuticals Ltd Logo
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Watchlist
Price: 1 259.15 INR -2.18% Market Closed
Market Cap: 320.5B INR
Have any thoughts about
Suven Pharmaceuticals Ltd?
Write Note

Suven Pharmaceuticals Ltd
Unrealized Security Profit/Loss

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Suven Pharmaceuticals Ltd
Unrealized Security Profit/Loss Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Unrealized Security Profit/Loss CAGR 3Y CAGR 5Y CAGR 10Y
Suven Pharmaceuticals Ltd
NSE:SUVENPHAR
Unrealized Security Profit/Loss
â‚ą237.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Unrealized Security Profit/Loss
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Suven Pharmaceuticals Ltd
Glance View

Market Cap
320.5B INR
Industry
Pharmaceuticals

Suven Pharmaceuticals Ltd. manufactures chemical products. The company is headquartered in Hyderabad, Telangana and currently employs 1,193 full-time employees. The company went IPO on 2020-03-09. The firm operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe and Rest of the World. In India, the Company sells bulk drugs and intermediates, fine chemicals and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In Rest of the World, the Company sells bulk drugs, intermediates and services. The Company’s wholly owned subsidiary is Suven Pharma Inc.

SUVENPHAR Intrinsic Value
402.41 INR
Overvaluation 68%
Intrinsic Value
Price

See Also

What is Suven Pharmaceuticals Ltd's Unrealized Security Profit/Loss?
Unrealized Security Profit/Loss
237.2m INR

Based on the financial report for Mar 31, 2024, Suven Pharmaceuticals Ltd's Unrealized Security Profit/Loss amounts to 237.2m INR.

What is Suven Pharmaceuticals Ltd's Unrealized Security Profit/Loss growth rate?
Unrealized Security Profit/Loss CAGR 1Y
121%

Over the last year, the Unrealized Security Profit/Loss growth was 121%.

Back to Top